423 related articles for article (PubMed ID: 28246485)
1. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
Soliman ML; Tiwari A; Zhao Q
World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
[TBL] [Abstract][Full Text] [Related]
2. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
3. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
[TBL] [Abstract][Full Text] [Related]
4. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
[TBL] [Abstract][Full Text] [Related]
5. Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital.
Scott N; West NP; Cairns A; Rotimi O
Histopathology; 2021 Jun; 78(7):963-969. PubMed ID: 33247957
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
Lee SM; Sung CO
Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
[TBL] [Abstract][Full Text] [Related]
7. Early signet ring cell carcinoma arising from colonic adenoma: the molecular profiling supports the adenoma-carcinoma sequence.
Bellan A; Cappellesso R; Lo Mele M; Peraro L; Balsamo L; Lanza C; Fassan M; Rugge M
Hum Pathol; 2016 Apr; 50():183-6. PubMed ID: 26997454
[TBL] [Abstract][Full Text] [Related]
8. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine and squamous colonic composite carcinoma: case report with molecular analysis.
Wentz SC; Vnencak-Jones C; Chopp WV
World J Gastroenterol; 2011 Nov; 17(42):4729-33. PubMed ID: 22180717
[TBL] [Abstract][Full Text] [Related]
10. Colon adenoma and adenocarcinoma with clear cell components - two case reports.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Okamoto K; Wada J; Urabe S; Daa T
Diagn Pathol; 2019 May; 14(1):37. PubMed ID: 31077226
[TBL] [Abstract][Full Text] [Related]
11. Medullary carcinoma of the colon: can the undifferentiated be differentiated?
Fiehn AM; Grauslund M; Glenthøj A; Melchior LC; Vainer B; Willemoe GL
Virchows Arch; 2015 Jan; 466(1):13-20. PubMed ID: 25339302
[TBL] [Abstract][Full Text] [Related]
12. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated medullary carcinoma of the colon with an unusual phenotypic profile mimicking high grade large cell lymphoma - a unique case report and review of the literature.
Nguyen J; Coppola D; Shan Y; Zhang L
Int J Clin Exp Pathol; 2014; 7(2):828-34. PubMed ID: 24551312
[TBL] [Abstract][Full Text] [Related]
14. Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.
Winn B; Tavares R; Fanion J; Noble L; Gao J; Sabo E; Resnick MB
Hum Pathol; 2009 Mar; 40(3):398-404. PubMed ID: 18992917
[TBL] [Abstract][Full Text] [Related]
15. Serrated adenoma of the stomach: a clinicopathologic, immunohistochemical, and molecular study of nine cases.
Kwon MJ; Min BH; Lee SM; Park HY; Kang SY; Ha SY; Lee JH; Kim JJ; Park CK; Kim KM
Histol Histopathol; 2013 Apr; 28(4):453-62. PubMed ID: 23404616
[TBL] [Abstract][Full Text] [Related]
16. [A case of colonic collision tumor (adenocarcinoma and neuroendocrine carcinoma)].
Kim DW; Kim SH; Yoon JM; Jun TY; Lee SJ; Kim YJ; Kim HY; Lee JS
Korean J Gastroenterol; 2012 Nov; 60(5):325-9. PubMed ID: 23172282
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
Pai RK; Mojtahed K; Pai RK
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):133-40. PubMed ID: 21307665
[TBL] [Abstract][Full Text] [Related]
18. In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.
Woischke C; Schaaf CW; Yang HM; Vieth M; Veits L; Geddert H; Märkl B; Stömmer P; Schaeffer DF; Frölich M; Blum H; Vosberg S; Greif PA; Jung A; Kirchner T; Horst D
Mod Pathol; 2017 Jan; 30(1):95-103. PubMed ID: 27586204
[TBL] [Abstract][Full Text] [Related]
19. Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma.
Wick MR; Vitsky JL; Ritter JH; Swanson PE; Mills SE
Am J Clin Pathol; 2005 Jan; 123(1):56-65. PubMed ID: 15762280
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.
Minarikova P; Benesova L; Halkova T; Belsanova B; Suchanek S; Cyrany J; Tuckova I; Bures J; Zavoral M; Minarik M
World J Gastroenterol; 2016 May; 22(20):4936-45. PubMed ID: 27239120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
